Status:

RECRUITING

Hybrid Functional Electrical Stimulation Exercise to Prevent Cardiopulmonary Declines in High-level Spinal Cord Injury

Lead Sponsor:

Spaulding Rehabilitation Hospital

Conditions:

Spinal Cord Injuries

Eligibility:

All Genders

18-40 years

Phase:

PHASE2

Brief Summary

Over the past ten years, the Cardiovascular Research Laboratory at Spaulding has refined a unique form of exercise for those with spinal cord injuries (SCI). Functional Electrical Stimulation Row Trai...

Detailed Description

Regular aerobic exercise with sufficient intensity can improve overall health, however daily energy expenditure is low in those with SCI, especially in those with high level lesions. The investigators...

Eligibility Criteria

Inclusion

  • SCI outpatients aged 18-45 years
  • medically stable
  • body mass index 18.5-30 kg/m2 to include normal to overweight but not obese individuals
  • 3-months to 6-years post-injury
  • ASIA Scale A, B, or C injury at or above neurological level T4
  • able to follow directions
  • wheelchair users
  • leg muscles responsive to stimulation

Exclusion

  • BP \>140/90 mmHg to exclude for hypertension (though rare in those with high level SCI)
  • current tobacco users
  • significant arrhythmias
  • coronary disease
  • diabetes
  • renal disease
  • cancer
  • epilepsy
  • current use of cardioactive medications (except medication to support blood pressure)
  • current grade 2 or greater pressure ulcers at relevant contact sites
  • other neurological disease
  • peripheral nerve compressions or rotator cuff tears that limit the ability to row
  • history of bleeding disorders
  • current use of buspirone
  • pregnancy
  • contraindications to Buspirone (taking MAO inhibitors, known hypersensitivity to buspirone, benzodiazepine dependence, akathisia, renal impairment, hepatic disease)

Key Trial Info

Start Date :

December 22 2020

Trial Type :

INTERVENTIONAL

Allocation :

ESTIMATED

End Date :

July 31 2026

Estimated Enrollment :

70 Patients enrolled

Trial Details

Trial ID

NCT04458324

Start Date

December 22 2020

End Date

July 31 2026

Last Update

January 4 2023

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Spaulding Hospital Cambridge

Cambridge, Massachusetts, United States, 02138